161 related articles for article (PubMed ID: 36253991)
21. The effect of EMG biofeedback assisted pelvic floor muscle therapy on symptoms of the overactive bladder syndrome in women: A randomized controlled trial.
Voorham JC; De Wachter S; Van den Bos TWL; Putter H; Lycklama À Nijeholt GA; Voorham-van der Zalm PJ
Neurourol Urodyn; 2017 Sep; 36(7):1796-1803. PubMed ID: 27869312
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
Salatzki J; Liechti MD; Spanudakis E; Gonzales G; Baldwin J; Haslam C; Pakzad M; Panicker JN
BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801
[TBL] [Abstract][Full Text] [Related]
23. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
[TBL] [Abstract][Full Text] [Related]
24. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
25. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
Yüce T; Dökmeci F; Çetinkaya ŞE
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
[TBL] [Abstract][Full Text] [Related]
26. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.
Tudor KI; Seth JH; Liechti MD; Ochulor J; Gonzales G; Haslam C; Fox Z; Pakzad M; Panicker JN
Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101
[TBL] [Abstract][Full Text] [Related]
27. Peroneal electrical transcutaneous neuromodulation in the home treatment of the refractory overactive bladder.
Krhut J; Rejchrt M; Slovak M; Dvorak RV; Grepl M; Zvara P
Int Urogynecol J; 2023 Jun; 34(6):1253-1260. PubMed ID: 36125509
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of Vibegron in treating overactive bladder: A systematic review and pooled analysis of randomized controlled trials.
Shi H; Chen H; Zhang Y; Cui Y
Neurourol Urodyn; 2020 Jun; 39(5):1255-1263. PubMed ID: 32421908
[TBL] [Abstract][Full Text] [Related]
29. Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men.
De Nunzio C; Brucker B; Bschleipfer T; Cornu JN; Drake MJ; Fusco F; Gravas S; Oelke M; Peyronnet B; Tutolo M; van Koeveringe G; Madersbacher S
Eur Urol; 2021 Apr; 79(4):492-504. PubMed ID: 33402296
[TBL] [Abstract][Full Text] [Related]
30. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
Rai BP; Cody JD; Alhasso A; Stewart L
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594
[TBL] [Abstract][Full Text] [Related]
31. Is the addition of vaginal electrical stimulation to transcutaneous tibial nerve electrical stimulation more effective for overactive bladder treatment? A randomized controlled trial.
Bacchi Ambrosano Giarreta F; Milhem Haddad J; Souza de Carvalho Fusco HC; Chada Baracat E; Casarotto RA; Alves Gonçalves Ferreira E
Actas Urol Esp (Engl Ed); 2021; 45(1):64-72. PubMed ID: 32660872
[TBL] [Abstract][Full Text] [Related]
32. Predictors of outcome in children and adolescents with overactive bladder treated with parasacral transcutaneous electrical nerve stimulation.
Hoffmann A; Sampaio C; Nascimento AA; Veiga ML; Barroso U
J Pediatr Urol; 2018 Feb; 14(1):54.e1-54.e6. PubMed ID: 28974365
[TBL] [Abstract][Full Text] [Related]
33. The efficacy and safety of medication for treating overactive bladder in patients with Parkinson's disease: a meta-analysis and systematic review of randomized double-blind placebo-controlled trials.
Cheng B; Huang S; Huang Q; Zhou Z; Bao Y
Int Urogynecol J; 2023 Sep; 34(9):2207-2216. PubMed ID: 37052644
[TBL] [Abstract][Full Text] [Related]
34. Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome.
Souto SC; Reis LO; Palma T; Palma P; Denardi F
World J Urol; 2014 Feb; 32(1):179-84. PubMed ID: 23749315
[TBL] [Abstract][Full Text] [Related]
35. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
Martin-Garcia M; Crampton J
Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
[TBL] [Abstract][Full Text] [Related]
36. A comparison of Kinesio taping and external electrical stimulation in addition to pelvic floor muscle exercise and sole pelvic floor muscle exercise in women with overactive bladder: a randomized controlled study.
Celenay ST; Karaaslan Y; Coban O; Oskay K
Disabil Rehabil; 2022 Sep; 44(18):5124-5132. PubMed ID: 34098818
[TBL] [Abstract][Full Text] [Related]
37. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
Chapple CR; Van Kerrebroeck PE; Jünemann KP; Wang JT; Brodsky M
BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
[TBL] [Abstract][Full Text] [Related]
38. Critical evaluation of the overactive bladder and urgency urinary incontinence association with obstructive sleep apnea syndrome in a relatively young adult male population.
Tuncer M; Yazici O; Kafkasli A; Sabuncu K; Salepci B; Narter F; Gungor GA; Yucetas U
Neurourol Urodyn; 2017 Sep; 36(7):1804-1808. PubMed ID: 27921319
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
Sonmez R; Yildiz N; Alkan H
Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
[TBL] [Abstract][Full Text] [Related]
40. Electrical stimulation with non-implanted electrodes for overactive bladder in adults.
Stewart F; Gameiro OL; El Dib R; Gameiro MO; Kapoor A; Amaro JL
Cochrane Database Syst Rev; 2016 Apr; 4():CD010098. PubMed ID: 27037009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
